Citeline l Pharma Intelligence

Citeline is the industry’s most comprehensive, reliable and current global R&D intelligence suite of solutions. Built by experts, made for experts, Citeline solutions transform data into knowledge. And now our new, next generation platform delivers unparalleled access to Citeline’s robust clinical trial intelligence. With greater ease, speed and efficiency than ever before, Citeline’s next generation platform will help you gain critical insights into the global clinical trial landscape and realize greater cost-savings as you develop on your clinical trial programs.

What Citeline does:

Citeline organizes vast quantities of data with human intelligence to greatly reduce research time, clinical trial costs and optimize trial outcomes. It features an unmatched collection of critical information on global clinical trials, investigators and sites, and drug development pipelines all with direct expert analyst support. Stay updated on what your competitors are doing with full public domain coverage of over 40,000 sources, continuous updating and full record reviews, advanced indexing and proprietary content.

Gain key insights that can be turned into actionable results with unparalleled access to 265,000+ clinical trials, 400,000 investigators, 68,000+ drugs, 117,000+ sites, 235+ diseases in 8 major therapeutic areas across 166 countries. And our 250+ therapeutic area experts and analysts are dedicated to provide the support needed so that you’re getting the most appropriate data to meet your requirements.

Citeline solutions:

If you are a Citeline subscriber, please access your login here.

Citeline

Whitepaper: Taking the 'High' Out of Pain

By Heidi Chen 11 Jun 2019

Twenty years ago, there was a shift in pain management, and it became more common to prescribe opioids for chronic pain.

Citeline, Pharmaprojects

Pharma RD Annual Review 2019 Supplement New Active Substances Launched During 2018

11 Jun 2019

Take the analysis from the Informa Pharma Intelligence R&D Annual Review 2019 further with the Pharma R&D Annual Review 2019 Supplement: New Active Substances Launched During 2018. This essential whitepaper uses critical data from Pharmaprojects to examine the new entities that were successfully launched to market last year.

Citeline

Clinical Trials Industry Report

By KNect365 11 Jun 2019

Clinical trials are continually evolving, particularly in light of increasing pressures from new technologies and other disruptors. Trends ranging from artificial intelligence (AI) and mHealth to patient-centricity are challenging the industry to innovate against the backdrop of looming regulatory changes and shifting competitor landscapes resulting from M&A activity. In order to explore these trends, KNect365 Life Sciences recently conducted one of the biggest surveys of its kind across clinical trial professionals from within pharma, CROs, sites, service providers, academia and patient groups across the world to look beyond the hype.

Citeline, Sitetrove, Trialtrove, Pharmaprojects

Citeline: Global Clinical Trial Intelligence Solutions

11 Jun 2019

Citeline is the industry’s most comprehensive, reliable and up-to-date global clinical trial intelligence suite, designed to help you save time and money by enrolling patients faster. Our team of more than 250 industry experts transform data into knowledge, integrating robust drug, trial, investigator, and site intelligence.

Citeline

Pharma Intelligence Congratulates The CARE Awards Winners

By Doro Shin 13 May 2019

The fourth annual CARE Awards returned to Boston, Massachusetts 2 May to once again recognize and commend key achievements across the spectrum of drug development that took place in 2018.

Citeline, Scrip, Pharmaprojects

Webinar Recording: Pharma R&D Review: What Changed In 2018, What To Look Out For In 2019

By Ian Lloyd 09 May 2019

April 17, 2019, Pharma R&D Review: What Changed In 2018, What To Look Out For In 2019

Citeline, Pharmaprojects

New Active Substances (NAS) LAUNCHED DURING 2018

17 Apr 2019

For a snapshot of the new active substances (NAS) successfully launched last year, download the data-packed New Active Substances (NAS) Launched During 2018 infographic from Citeline.

Citeline

Horizons in HIV Drug Development – What’s Past is Prologue

By Avery Levine 10 Apr 2019

While AIDS therapy was once confined to palliative care, clinical progress in the wake of the landmark 1987 approval of zidovudine has seen HIV demoted to a chronic but manageable infection. Following the initial fledgling steps and missteps, the mid-1990s saw the introduction of the now-familiar three-drug combination regimens that raised expectations for a pharmaceutical solution to the epidemic.

Citeline

Taking the High Out of Pain: Exploring Abuse-Deterrent Opioids and Opioid Alternatives

10 Apr 2019

With opioid abuse and deaths in the US at an all-time high, the journey to battle the opioid epidemic continues – keeping drug companies and the FDA working hard to come up with effective alternatives for pain.

Citeline

Immuno-Oncology (IO) in Non-Small Cell Lung Cancer (NSCLC)

By Kimberly Rader 23 Nov 2018

A clinical review of the competitive landscape, approved therapies, trial outcomes and experienced investigators in this highly targeted space.

Citeline, Citeline Analytics

2017 Completed Clinical Trials: Status Quo or No Webinar Recording

By Laura Runkel 08 Nov 2018

For a deeper look into the data behind last year’s completed clinical trials and the trends driving them, Listen to the Completed Clinical Trials 2017: Status Quo or No?

Citeline

Depression New Insights Shifting the Treatment Paradigm Whitepaper

By Pippa Nutkins 05 Nov 2018

Depression affects approximately 1 in 6 Americans, with 10 – 30% of depression patients becoming treatment-resistant. Find out what the pipeline looks like for depression and what the emerging strategies in this area are. This data-packed whitepaper from Informa Pharma Intelligence can now be downloaded – free.

Citeline, Trialtrove

Rheumatoid Arthritis - Old and New Approaches Shifting the Treatment Paradigm

By Laura Runkel 19 Oct 2018

Explore the current and future outlook for rheumatoid arthritis (RA) treatments. Such treatments remain ineffective for the 33% of RA sufferers who are or become unresponsive to treatment, resulting in a high interest in RA drug development to address this unmet need in the marketplace.

Citeline

2017 Completed Clinical Trials: Disease and Sponsor Assessment in 9 Key Tables

02 Aug 2018

Citeline’s completed clinical trial landscape provides a more granular view of how companies are progressing their pipelines and the disease strategies they are pursuing, compared to static pipeline snapshots.

Citeline, Scrip, Biomedtracker, Datamonitor Healthcare

ASCO Essentials Webinar 2018 Recording

By Mary Jo Laffler 29 May 2018

Just in time for your 2018 ASCO Annual Meeting planning, join analysts from Datamonitor Healthcare, Biomedtracker, Citeline, Scrip, and Pink Sheet for their expert opinions on what you need to know to get the most from the meeting. Let our experts present their top picks from the thousands of abstracts being presented at ASCO.

What is Citeline?

Related products

Below are the Product Brand List

Sitetrove: Clinical trial site & investigator identification

Trialtrove: gold standard clinical trials intelligence

Pharmaprojects: track pharma R&D

Citeline Analytics

Pharma Intelligence: latest

Whitepaper: Taking the 'High' Out of Pain

Pharma RD Annual Review 2019 Supplement New Active Substances Launched During 2018

Clinical Trials Industry Report

Citeline: Global Clinical Trial Intelligence Solutions

Pharma Intelligence Congratulates The CARE Awards Winners

Webinar Recording: Pharma R&D Review: What Changed In 2018, What To Look Out For In 2019

New Active Substances (NAS) LAUNCHED DURING 2018

Horizons in HIV Drug Development – What’s Past is Prologue

Taking the High Out of Pain: Exploring Abuse-Deterrent Opioids and Opioid Alternatives

Immuno-Oncology (IO) in Non-Small Cell Lung Cancer (NSCLC)

2017 Completed Clinical Trials: Status Quo or No Webinar Recording

Depression New Insights Shifting the Treatment Paradigm Whitepaper

Rheumatoid Arthritis - Old and New Approaches Shifting the Treatment Paradigm

2017 Completed Clinical Trials: Disease and Sponsor Assessment in 9 Key Tables

ASCO Essentials Webinar 2018 Recording

Meet the team

Below are the Analyst Profile

Susan Danheiser

Management, Director

Next steps

This is Contactus Section

Request a Demo

How can we help you?

Pharma Report Store